Johannes F Mann

Johannes F Mann

UNVERIFIED PROFILE

Are you Johannes F Mann?   Register this Author

Register author
Johannes F Mann

Johannes F Mann

Publications by authors named "Johannes F Mann"

Are you Johannes F Mann?   Register this Author

100Publications

2141Reads

16Profile Views

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Kidney Int 2019 May;95(5):1027-1036

KfH Kidney Center, Munich, Germany; Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander University, Erlangen-Nuremberg, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2018.12.025DOI Listing
May 2019

Health-related quality of life in people with type 2 diabetes participating in the LEADER trial.

Diabetes Obes Metab 2019 03 25;21(3):525-532. Epub 2018 Oct 25.

Nuffield Department of Population Health, Health Economics Research Centre, University of Oxford, Oxford, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/dom.13547DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587748PMC
March 2019

A Mendelian Randomization-Based Approach to Identify Early and Sensitive Diagnostic Biomarkers of Disease.

Clin Chem 2019 Mar 18;65(3):427-436. Epub 2018 Oct 18.

Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2018.291104DOI Listing
March 2019

LEADER-6: Baseline renal function and associated factors in a high cardiovascular risk type 2 diabetes population.

J Diabetes Complications 2016 Nov - Dec;30(8):1631-1639. Epub 2016 Jun 3.

Department of Nephrology, Hypertension & Rheumatology, Friedrich Alexander University of Erlangen, Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jdiacomp.2016.06.001DOI Listing
March 2018

Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.

Am J Med 2017 12 31;130(12):1465.e27-1465.e39. Epub 2017 Aug 31.

Department of Medicine and Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2017.05.047DOI Listing
December 2017

Liraglutide and Renal Outcomes in Type 2 Diabetes.

N Engl J Med 2017 11;377(22):2197-2198

University of North Carolina School of Medicine, Chapel Hill, NC

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1713042DOI Listing
November 2017

Liraglutide and Renal Outcomes in Type 2 Diabetes.

N Engl J Med 2017 08;377(9):839-848

From KfH Kidney Center, Munich, and Friedrich Alexander University of Erlangen, Erlangen - both in Germany (J.F.E.M.); Novo Nordisk, Bagsvaerd, Denmark (D.D.Ø., K.B.-F., S.R., K.T.); University of Texas Southwestern Medical Center, Dallas (S.P.M.); Imperial College London, London (N.R.P.); Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto (B.Z.); and University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1616011DOI Listing
August 2017

Mortality in dialysis patients with cinacalcet use: A large observational registry study.

Eur J Intern Med 2017 Jul 10;42:89-95. Epub 2017 May 10.

Department of Internal Medicine, Clinical Division of Nephrology, Medical University of Graz, Auenbruggerplatz 27, A-8036 Graz, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejim.2017.05.002DOI Listing
July 2017

Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.

Kidney Int 2017 03 4;91(3):683-690. Epub 2016 Dec 4.

Departments of Nephrology and Hypertension, Friedrich Alexander University, Erlangen, Bavaria, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2016.09.038DOI Listing
March 2017

Diet and Major Renal Outcomes: A Prospective Cohort Study. The NIH-AARP Diet and Health Study.

J Ren Nutr 2016 09 12;26(5):288-98. Epub 2016 Mar 12.

Health Research Board Clinical Research Facility Galway, National University of Ireland, Galway, Ireland; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.jrn.2016.01.016DOI Listing
September 2016

Population-Attributable Fractions of Modifiable Lifestyle Factors for CKD and Mortality in Individuals With Type 2 Diabetes: A Cohort Study.

Am J Kidney Dis 2016 Jul 30;68(1):29-40. Epub 2016 Jan 30.

Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria; Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2015.12.019DOI Listing
July 2016

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

N Engl J Med 2016 07 13;375(4):311-22. Epub 2016 Jun 13.

From the University of Texas Southwestern Medical Center, Dallas (S.P.M.); Massachusetts General Hospital, Boston (G.H.D.); Novo Nordisk, Bagsvaerd, Denmark (K.B.-F., P.K., L.S.R., M.S.); Friedrich Alexander University of Erlangen, Erlangen (J.F.E.M.), and St. Josef Hospital, Ruhr University, Bochum (M.A.N.) - both in Germany; Cleveland Clinic, Cleveland (S.E.N.); London School of Hygiene and Tropical Medicine Medical Statistics Unit (S.P.) and Imperial College London (N.R.P.), London; George Washington University Medical Center, Washington, DC (W.M.S.); Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, Toronto (B.Z.); International Diabetes Center at Park Nicollet, Minneapolis (R.M.B.); and the University of North Carolina School of Medicine, Chapel Hill (J.B.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1603827DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985288PMC
July 2016

LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial.

J Hypertens 2016 06;34(6):1140-50

aInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK bDivision of Cardiology, Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA cInstitute of Life Science, College of Medicine, Swansea University Medical School, Swansea, UK dMossakowski Medical Research Centre, Polish Academy of Sciences eDepartment of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital MSW, Warsaw, Poland fKardio Metabolischen Instituts, Villingen-Schwenningen, Germany gEndocrinology and Nutrition Department, Hospital Son Llàtzer, University Institute of Health Science Research (IUNICS)-Universitat de les Illes Balears, Palma de Mallorca, Spain hDivisions of Endocrinology & Metabolism, Li Ka Shing Knowledge Institute and Keenan Research Centre for Biomedical Science, St. Michael's Hospital, University of Toronto, Ontario, Canada i1st Faculty of Medicine and General University Hospital, Charles University in Prague, Prague, Czech Republic jDivision of Endocrinology and Metabolism, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey kDepartment of Diabetes and Endocrinology, Nelson R Mandela School of Medicine, University of KwaZulu Natal, South Africa lEndocrinology Research Centre, Diabetes Institute mI.M. Sechenov First Moscow State Medical University, Moscow, Russian Federation nFaculty of Medicine, Antwerp University Hospital, Antwerp, Belgium oDepartment of Nephrology, Hypertension & Rheumatology, Friedrich Alexander University of Erlangen, Munchen, Germany pNovo Nordisk, A/S, Bagsvaerd, Denmark qLunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Canada rInternational Centre for Circulatory Health, Imperial College London, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0000000000000890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4856174PMC
June 2016

Long-term effects following 4 years of randomized treatment with atorvastatin in patients with type 2 diabetes mellitus on hemodialysis.

Kidney Int 2016 06 17;89(6):1380-7. Epub 2016 Feb 17.

Department of Internal Medicine I, Division of Nephrology, University of Würzburg, Würzburg, Germany; Comprehensive Heart Failure Centre, University of Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.kint.2015.12.033DOI Listing
June 2016

Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.

N Engl J Med 2015 Dec;373(23):2225-36

From the Division of Nephrology and Clinical Immunology (T.R., F.E., J.F.) and Department of Medical Statistics (C.F., R.-D.H.), RWTH Aachen University, Aachen, Bayer Pharma, Kidney Diseases Research, Wuppertal (F.E.), Department of Nephrology, University of Heidelberg, Heidelberg (C.S., M.Z.), Internal Medicine D, Department of Nephrology, Hypertension and Rheumatology, University Hospital Muenster, Muenster (B.O.), University Medical Center Hamburg-Eppendorf, Hamburg (U.P.), Department of Nephrology and Dieter Scheffner Center for Medical Education, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin (H.P.), Department of Medicine V, University Medical Center Mannheim, University of Heidelberg, Mannheim (U.B.), Department of Nephrology and Hypertension, Diabetes and Endocrinology, Otto-von-Guericke University, Magdeburg (P.R.M.), Medical Clinic III, Central Hospital Bremen, Bremen (U.K.), Department of Nephrology, University Hospital Essen, University of Duisburg-Essen, Essen (O.W.), Clinic for Nephrology and Rheumatology, University Medical Center Goettingen, Goettingen (O.G.), and Nephrologisches Zentrum, Medizinische Klinik und Poliklinik IV, Klinikum der Ludwig-Maximilians-Universität (V.V.), and Department of Nephrology, Hypertension and Rheumatology, Munich General Hospital (J.F.E.M.), Munich - all in Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1415463DOI Listing
December 2015

Risk Prediction for Early CKD in Type 2 Diabetes.

Clin J Am Soc Nephrol 2015 Aug 14;10(8):1371-9. Epub 2015 Jul 14.

Section for Clinical Biometrics, Center for Medical Statistics, Informatics and Intelligent Systems, Medical University of Vienna, Vienna, Austria; Hospital Elisabethinen Linz, Linz, Austria; and Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.10321014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527032PMC
August 2015

Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?

Nephrol Dial Transplant 2015 Aug;30 Suppl 4:iv1-5

Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria.

View Article

Download full-text PDF

Source
https://academic.oup.com/ndt/article-lookup/doi/10.1093/ndt/
Publisher Site
http://dx.doi.org/10.1093/ndt/gfv120DOI Listing
August 2015

Genome-wide studies to identify risk factors for kidney disease with a focus on patients with diabetes.

Nephrol Dial Transplant 2015 Aug;30 Suppl 4:iv26-34

Division of Internal Medicine 3, Department of Nephrology and Dialysis, Medical University Vienna, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfv087DOI Listing
August 2015

Dual renin-angiotensin system blockade and outcome benefits in hypertension: a narrative review.

Curr Opin Cardiol 2015 Jul;30(4):373-7

aDepartment of Medicine, Friedrich Alexander University, Erlangen-Nürnberg, Germany bPopulation Health Research Institute, McMaster University, Hamilton, Canada cUniversity of the Saarland, Homburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/HCO.0000000000000173DOI Listing
July 2015

Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus.

Kidney Int 2015 Apr 10;87(4):784-91. Epub 2014 Dec 10.

1] Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, ON, Canada [2] University of Erlangen-Nürnberg, Department of Nephrology, Erlangen, Germany [3] Schwabing General Hospital, and KfH Kidney Center, Munich, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00852538153021
Publisher Site
http://dx.doi.org/10.1038/ki.2014.370DOI Listing
April 2015

Multiple sclerosis-like lesions and type I interferon signature in a patient with RVCL.

Neurol Neuroimmunol Neuroinflamm 2015 Feb 23;2(1):e55. Epub 2014 Dec 23.

Institute of Clinical Neuroimmunology (E.S., R.H., T.K.) and Institute of Clinical Radiology (B.E.-W.), Ludwig-Maximilians University, Munich, Germany; Department of Neuroimmunology (E.S.), Center of Brain Research, Vienna, Austria; Institute of Laboratory Medicine and Human Genetics (P.L.), Singen, Germany; Department of Ophthalmology (W.W.), Outpatient Clinic Neuhann, Munich, Germany; Department of Nephrology (J.F.M.), Clinical Centre Schwabing, Munich, Germany; Department of Pediatrics (M.A.L.-K.), Technische Universität Dresden, Germany; and Munich Cluster for Systems Neurology (SyNergy) (R.H.), Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000055DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277301PMC
February 2015

Multiglandular hormone deficiency in a patient with systemic capillary leak syndrome.

Case Rep Med 2015 5;2015:958283. Epub 2015 Jan 5.

Medizinische Klinik und Poliklinik IV, Klinikum der Universität München, Ziemssenstrasse 1, 80336 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/958283DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313677PMC
February 2015

The relationship between estimated sodium and potassium excretion and subsequent renal outcomes.

Kidney Int 2014 Dec 11;86(6):1205-12. Epub 2014 Jun 11.

Department of Nephrology, McMaster University, Hamilton, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2014.214DOI Listing
December 2014

LEADER 3--lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the LEADER Trial.

Pancreas 2014 Nov;43(8):1223-31

From the *Department of Medicine, George Washington University Medical Center, Rockville, MD; †Department of Internal Medicine/Diabetology, Diabeteszentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany; ‡Department of Medicine, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada; §Thyroid Unit and Department of Medicine, Massachusetts General Hospital Harvard Medical School, Boston, MA; ║Park Nicollet Institute for Research and Education, International Diabetes Center, Minneapolis, MN; ¶Department of Medicine, Friedrich Alexander University of Erlangen, Erlangen, Germany; #Novo Nordisk, A/S, Bagsvaerd, Denmark; **Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern, Dallas, TX; and ††Division of Endocrinology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPA.0000000000000229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206347PMC
November 2014

Sodium intake and renal outcomes: a systematic review.

Am J Hypertens 2014 Oct 7;27(10):1277-84. Epub 2014 Feb 7.

Population Health Research Institute, Hamilton, Ontario, Canada; Friedrich Alexander University of Erlangen, Germany; Department of Nephrology, Hypertension & Rheumatology, Munich General Hospitals, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ajh/hpt294DOI Listing
October 2014

The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.

Eur J Prev Cardiol 2014 Mar 4;21(3):299-309. Epub 2013 Nov 4.

Department of Clinical Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2047487313510678DOI Listing
March 2014

Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.

Clin J Am Soc Nephrol 2014 Mar 9;9(3):490-8. Epub 2014 Jan 9.

Department of Clinical Pharmacology, University of Groningen, University Medical Center, Groningen, The Netherlands;, †King's College London School of Medicine, Guy's Hospital, London, United Kingdom;, ‡Quintiles Ltd., Strasbourg, France;, §Schwabing General Hospital, Munich, Germany;, ‖Department of Medicine IV, University of Erlangen, Erlangen, Germany, ¶KfH Kidney Centre, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.07040713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944766PMC
March 2014

Endothelin antagonism for patients with chronic kidney disease: still a hope for the future.

Nephrol Dial Transplant 2014 Feb;29 Suppl 1:i69-i73

Department of Nephrology and Hypertension, University of Erlangen-Nuremberg and Nuremberg General Hospital, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gft339DOI Listing
February 2014

How does hemodiafiltration improve survival?

Authors:
Johannes F Mann

Kidney Int 2013 Dec;84(6):1287-8

Department of Nephrology and Hypertension, Ludwig Maximilians University, Schwabing General Hospital, Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2013.388DOI Listing
December 2013

Renal sympathetic denervation as antihypertensive therapy--a reappraisal of first results.

Nephrol Dial Transplant 2013 Nov 14;28(11):2698-701. Epub 2013 Aug 14.

Medizinische Klinik 4 (Nephrologie und Hypertensiologie), Friedrich Alexander Universitaet Erlangen-Nuernberg, Erlangen-Nuremberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gft017DOI Listing
November 2013

Dual RAS blockade-unresolved controversy?

Nat Rev Nephrol 2013 Nov 10;9(11):640. Epub 2013 Sep 10.

St Luke's Roosevelt Hospital, Columbia University College of Physicians & Surgeons, 1111 Amsterdam Avenue, New York, NY 10019, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrneph.2013.82-c1DOI Listing
November 2013

Research needs in the area of device-related treatments for hypertension.

Kidney Int 2013 Aug 27;84(2):250-5. Epub 2013 Feb 27.

Hannover Medical School, Institute of Clinical Pharmacology, Hannover, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ki.2013.56DOI Listing
August 2013

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Lancet 2013 Jul 31;382(9889):339-52. Epub 2013 May 31.

Department of Nephrology, University Medical Centre Groningen, University Hospital Groningen, Groningen, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)60595-4DOI Listing
July 2013

Albuminuria and rapid loss of GFR and risk of new hip and pelvic fractures.

Clin J Am Soc Nephrol 2013 Feb 26;8(2):233-40. Epub 2012 Nov 26.

Division of Endocrinology, Emory University School of Medicine, Atlanta, Georgia, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2215/CJN.06640712DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3562864PMC
February 2013

Urinary sodium and potassium excretion and risk of cardiovascular events.

JAMA 2011 Nov;306(20):2229-38

Population Health Research Institute, Hamilton General Hospital, McMaster University, 237 Barton St E, Third Floor, Hamilton, ON, L8L 2X2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2011.1729DOI Listing
November 2011

Changes in albuminuria predict mortality and morbidity in patients with vascular disease.

J Am Soc Nephrol 2011 Jul 30;22(7):1353-64. Epub 2011 Jun 30.

Department of Nephrology and Hypertension, University Hospital, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2010091001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137583PMC
July 2011

Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies.

Circulation 2011 Mar 28;123(10):1098-107. Epub 2011 Feb 28.

Division of Nephrology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.110.9
Publisher Site
http://dx.doi.org/10.1161/CIRCULATIONAHA.110.964171DOI Listing
March 2011

What's new in hypertension 2010?

Nephrol Dial Transplant 2011 Jan;26(1):50-5

Munich General Hospitals, and KfH Kidney Centre, Munich and Friedrich Alexander University Erlangen-Nürnberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfq776DOI Listing
January 2011

Albuminuria and decline in cognitive function: The ONTARGET/TRANSCEND studies.

Arch Intern Med 2011 Jan;171(2):142-50

Kaiser Permanente of Georgia, Emory University School of Medicine, Atlanta, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archinternmed.2010.502DOI Listing
January 2011

Avosentan for overt diabetic nephropathy.

J Am Soc Nephrol 2010 Mar 18;21(3):527-35. Epub 2010 Feb 18.

Schwabing General Hospital, and Department of Medicine IV, University of Erlangen and KfH Kidney Centre, Munich, Germany.

View Article

Download full-text PDF

Source
http://www.jasn.org/cgi/doi/10.1681/ASN.2009060593
Publisher Site
http://dx.doi.org/10.1681/ASN.2009060593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831858PMC
March 2010

Is therapy of people with chronic kidney disease ONTARGET?

Nephrol Dial Transplant 2010 Jan 23;25(1):42-4. Epub 2009 Oct 23.

Population Health Research Institute, McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://ndt.oxfordjournals.org/content/25/1/42.full.pdf
Web Search
http://ndt.oxfordjournals.org/cgi/doi/10.1093/ndt/gfp568
Publisher Site
http://dx.doi.org/10.1093/ndt/gfp568DOI Listing
January 2010

What's new in hypertension 2009?

Nephrol Dial Transplant 2010 Jan;25(1):37-41

Munich General Hospitals, and KfH Kidney Centre, Munich and Friedrich Alexander University Erlangen-Nürnberg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfp703DOI Listing
January 2010

Glycoprotein IIb/IIIa receptor inhibition with abciximab during percutaneous coronary interventions increases the risk of bleeding in patients with impaired renal function.

Cardiology 2008 23;111(4):247-53. Epub 2008 Apr 23.

Deutsches Herzzentrum und Medizinische Klinik rechts der Isar, Technische Universitat und Medizinische Abteilung fur Nieren- und Hochdruckerkrankungen, Stadtisches Krankenhaus Munchen-Schwabing, Munchen, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000127446DOI Listing
January 2009

What's new in hypertension 2008?

Nephrol Dial Transplant 2009 Jan 25;24(1):38-42. Epub 2008 Nov 25.

Department of Nephrology and Hypertension, Schwabing General Hospital, LMU and KfH Kidney Center, Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfn642DOI Listing
January 2009

The choice of antihypertensive therapy in patients with the metabolic syndrome--time to change recommendations?

Nephrol Dial Transplant 2008 Nov 7;23(11):3389-91. Epub 2008 Aug 7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfn455DOI Listing
November 2008

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study.

Nephrol Dial Transplant 2008 Feb 14;23(2):645-53. Epub 2007 Nov 14.

Department of Medicine, Munich General Hospitals and KfH Kidney Centre, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfm485DOI Listing
February 2008

What's new in hypertension 2007?

Nephrol Dial Transplant 2008 Feb 25;23(2):466-70. Epub 2008 Jan 25.

Munich General Hospitals, Ludwig Maximilians University Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfm904DOI Listing
February 2008

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Ann Intern Med 2008 Jan 5;148(1):30-48. Epub 2007 Nov 5.

Basel Institute for Clinical Epidemiology and Clinic for Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7326/0003-4819-148-1-200801010-00190DOI Listing
January 2008

Chronic kidney disease: effects on the cardiovascular system.

Circulation 2007 Jul;116(1):85-97

Department of Medicine, Sir Mortimer B. Davis Jewish General Hospital, McGill University, Montreal, Quebec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.678342DOI Listing
July 2007

Renal function and outcomes in acute coronary syndrome: impact of clopidogrel.

Eur J Cardiovasc Prev Rehabil 2007 Apr;14(2):312-8

Gottsegen György Hungarian Institute of Cardiology, Department of Cardiology, Semmelweis University, Budapest, Hungary.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.hjr.0000220582.19516.a6DOI Listing
April 2007

Dialyzer membrane characteristics and outcome of patients with type 2 diabetes on maintenance hemodialysis.

Am J Kidney Dis 2007 Feb;49(2):267-75

University of Würzburg, Department of Medicine, Division of Nephrology, University Hospital Würzburg.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2006.11.026DOI Listing
February 2007

What's new in hypertension?

Nephrol Dial Transplant 2007 Jan 11;22(1):47-52. Epub 2006 Nov 11.

Department of Nephrology and Hypertension, Munich General Hospitals, LMU, Kolner Platz 1, D-80804 Munchen, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/ndt/gfl656DOI Listing
January 2007

Reevaluation by high-performance liquid chromatography: clinical significance of microalbuminuria in individuals at high risk of cardiovascular disease in the Heart Outcomes Prevention Evaluation (HOPE) Study.

Am J Kidney Dis 2006 Dec;48(6):889-96

Hamilton Regional Laboratory Medicine Program, Department of Pathology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S027263860601440
Publisher Site
http://dx.doi.org/10.1053/j.ajkd.2006.09.003DOI Listing
December 2006

Clinic versus home blood-pressure measurements as a predictor of outcomes in chronic kidney disease.

Nat Clin Pract Nephrol 2006 Sep;2(9):474-5

Department of Nephrology and Hypertension, Schwabing City Hospital, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncpneph0237DOI Listing
September 2006

Renoprotective effects of renin-angiotensin-system inhibitors.

Lancet 2006 Mar;367(9514):900; author reply 900-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(06)68375-XDOI Listing
March 2006

Apolipoprotein A-IV predicts progression of chronic kidney disease: the mild to moderate kidney disease study.

J Am Soc Nephrol 2006 Feb 28;17(2):528-36. Epub 2005 Dec 28.

Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Schöpfstrasse 41, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1681/ASN.2005070733DOI Listing
February 2006

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

N Engl J Med 2005 Jul;353(3):238-48

Division of Nephrology, Department of Medicine, University of Würzburg, Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa043545DOI Listing
July 2005

Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease.

Am Heart J 2005 Jan;149(1):54-60

Department of Cardiology, Laval University Heart and Lung Institute, Ste-Foy, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2004.07.009DOI Listing
January 2005

Albuminuria as a predictor of cardiovascular and renal outcomes in people with known atherosclerotic cardiovascular disease.

Kidney Int Suppl 2004 Nov(92):S59-62

Department of Cardiology and of Endocrinology, and Population Health Research Institute, McMaster University, Hamilton, Canada.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S008525381550401
Publisher Site
http://dx.doi.org/10.1111/j.1523-1755.2004.09215.xDOI Listing
November 2004

Coronary revascularization in patients with renal insufficiency: restenosis rate and cardiovascular outcomes.

Am J Kidney Dis 2004 Oct;44(4):627-35

Deutsches Herzzentrum, Technische Universität, Munich, Germany.

View Article

Download full-text PDF

Source
October 2004

Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?

Pediatr Nephrol 2004 Sep 22;19(9):956-61. Epub 2004 Jul 22.

Department of Medicine IV, University of Erlangen-Nürnberg, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00467-004-1554-5DOI Listing
September 2004

Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.

Am J Cardiovasc Drugs 2002 ;2(3):157-62

Department of Nephrology and Hypertension, Schwabing General Hospital, Ludwig Maximilians University, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/00129784-200202030-00003DOI Listing
April 2004

How does minor renal dysfunction influence cardiovascular risk and the management of cardiovascular disease?

J Am Soc Nephrol 2004 Mar;15(3):517-23

Department of Cardiology, German Heart Center, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.asn.0000107565.17553.71DOI Listing
March 2004

Effects of low dose ramipril on cardiovascular and renal outcomes in patients with type 2 diabetes and raised excretion of urinary albumin: randomised, double blind, placebo controlled trial (the DIABHYCAR study).

BMJ 2004 Feb 11;328(7438):495. Epub 2004 Feb 11.

Endocrinologie-Diabétologie-Nutrition, Groupe Hospitalier Bichat-Claude Bernard, Assistance Publique des Hôpitaux de Paris, 46 rue Henri Huchard, 75877 Paris Cedex 18, France.

View Article

Download full-text PDF

Source
http://www.bmj.com/lookup/doi/10.1136/bmj.37970.629537.0D
Publisher Site
http://dx.doi.org/10.1136/bmj.37970.629537.0DDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC351842PMC
February 2004